Management of meningioma

Summary Meningiomas are the most frequent primary brain tumors, accounting for ∼37% of central nervous systems tumors. Despite being largely benign, clinicians frequently face difficult treatment decisions in cases with complex morphology or localisation, near vital brain structures such as the optic nerve or in the case of incidental tumors. Here, we review current concepts of diagnosis, treatment and follow-up with clinical decision-making informed by multimodal imaging, histology, and molecular biology. In this issue Editorial : Neuro-oncology: a rapidly evolving multidisciplinary speciality. A. Idbaih (France) The 2016 World Health Organization classification of tumors of the central nervous system. C. Villa et al. (France, Belgium, UK) Management of diffuse gliomas. I. Esparragosa et al. (Spain) Management of primary Central Nervous System Lymphoma. L. Royer-Perron et al. (France) Management of meningioma. P. Euskirchen et al. (Germany, France) Neuromuscular complications of immune checkpoint inhibitors. D. Psimaras (France)